• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » HeartFlow inks collab research deal with Imperial College London

HeartFlow inks collab research deal with Imperial College London

March 9, 2018 By Fink Densford

HeartFlow

HeartFlow said on Wednesday it inked a collaborative research agreement deal with the Imperial College London for research in the areas of medical imaging and deep learning using the company’s FFRct technology.

Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary lesions.

The collaborative project will be led by Dr. Ben Glocker and Daniel Rueckert, Heartflow said. As part of the project, a team from Heartflow will operate out of Imperial’s Biomedical Image Analysis group

“The collaboration with HeartFlow will not only open new and exciting research directions, but it also will pave the path for bringing our latest deep learning technology into clinical practice and thus will have real impact on the healthcare of thousands of patients. This collaboration provides us with the optimal infrastructure to go beyond publishing papers and turn our ideas into new clinical solutions,” Dr. Glocker said in a prepared statement.

“The HeartFlow collaboration is a new type of industrial collaboration and we see great mutual benefit from a truly embedded team of scientists that will work closely with our academic staff, postdocs and PhD students. This model provides us new ways of attracting the best talent and offering exciting research opportunities,” Rueckert said in a prepared release.

The project will initially focus on developing algorithms for extracting models of the coronaries from 4D computed tomography datasets, aligning images across modalities and improving the precision of image acquisition and reconstruction. HeartFlow said it will also fund additional research roles at the lab.

“We are delighted to collaborate with the team at Imperial, who are globally recognized leaders in applying deep learning techniques to medical imaging. I have no doubt that the combined expertise of the HeartFlow and Imperial teams will help accelerate turning cutting-edge science into groundbreaking products that can positively impact how patients with suspected heart disease are diagnosed and managed,” prez & CEO Dr. John Stevens said in a press release.

Last month, HeartFlow said it closed a $240 million Series E round of financing, with funds slated to support commercial expansion and studies of its HeartFlow FFRct analysis system.

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Research & Development, Software / IT Tagged With: HeartFlow

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy